Strony

Friday, June 4, 2021

Dr. Michael J. Burry's Big Short Tesla Play

Dr. Michael J. Burry - a well known investor who predicted a financial crisis in 2008 - runs Scion Asset Management (SAM). Scion Asset Management is a hedge fund based out of Saratoga and consists of  5 clients and discretionary assets under management (AUM) of $638,901,404 (Form ADV from 2021-03-31). SAM's last reported 13F filing for Q1 2021 included $1,353,930,000 in managed 13F securities.

The following table presents a top 10 holdings with a concentration of 91.57% SAM's portfolio. 


Table 1 Top 10 holdings of SAM.

What is interesting is that Scion Asset Management's bets that Tesla's value will crash. PUT contracts are worth $534,411,000 and it constitutes 39.47% of SAM's portfolio. 13F does not tell us when put contracts expire.  

Tesla closed at $572.84 in June 3, 2021.


 Time will show us whether it is a perfect bet.





Monday, February 8, 2021

Tesla invests in Bitcoin

In January 2021, Tesla updated investment policy to provide with more flexibility to further diversify and maximize returns on cash that is not required to maintain adequate operating liquidity. As part of the policy,  Thereafter, Tesla invested an aggregate $1.50 billion in bitcoin under this policy and may acquire and hold digital assets from time to time or long-term. Moreover, the company expects to begin accepting bitcoin as a form of payment for our products in the near future, subject to applicable laws and initially on a limited basis, which we may or may not liquidate upon receipt.


The price of Bitcoin has significantly surged  after Tesla's 10-K report announcement. More info you can find within the Edgar database





Wednesday, January 6, 2021

Riot escalates at Capitol

2020 was though. But 2021 doesn't slow down. The supporters of the US president breached US Capitol. It's hot inside as presented in the following picture. 


Donal Trump replied that election was stolen and asked protesters to go home.


Dow Jones almost hit the new record.

Thursday, December 17, 2020

The bullish market with new ATH

 The US stock markets post new records:

  • DOW JONES - 30,301.79
  • S&P 500 - 3,722.43
  • NASDAQ - 12,764.75
  • RUSSELL 2000 - 1,978.05 




Tuesday, November 24, 2020

Dow Jones, S&P 500 post record closing highs

The Dow and S&P 500 hit a record closing highs on Monday after Moderna became the latest major drug-maker to announce upbeat data (94.5% effective in preventing COVID-19 in participants.) building on hopes that an effective vaccination will soon be available.



Thursday, November 12, 2020

Pfizer - what the media don't tell you?

Pfizer Inc. corporation - one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list - is supposed to be Covid-19 game changer after it showed strong results in trials. Stock markets significantly reacted but not only. For instance, only the European Union has agreed to buy up to 300 million doses of the coronavirus vaccine.


That what the media say right now. But there are more interesting stories about Pfizer that are happening now and nobody wants talk about 'not interesting' facts. Within this post, we list a few facts that each investor should catch an eye on Pfizer and German-related company BioNTech that can found in a quarterly securities filing of Pfizer. Here is a list of untold stories:

1) The U.S. Securities and Exchange Commission (SEC) and the Department of Justice (DOJ) are looking into Pfizer's operations in China, Russia and India. Both requests fall under the Foreign Corrupt Practices Act (FCPA), which forbids U.S. firms and individuals from bribing foreign government officials to benefit their businesses. Only in 2012, Pfizer agreed to pay over $60 million to settle charges by the SEC and DOJ for allegedly violating the FCPA.

2)  In March 2020, Pfizer Inc. paid $200 million to California consumers for the alleged off-label marketing of its harmful hormone therapy products. The case was originally filed in December 2003.

3) The U.S. Department of Justice Antitrust Division Investigation investigates not transparent Greenstone generics business which may pursue a suit for the recovery of civil damages and penalties on behalf of the government.

4) Biogen Idec MA Inc. filed patent litigation against Pfizer which is pending in the U.S. District Court for the District of New Jersey and the United States Court of Appeals for the Federal Circuit. Company has acknowledged that it is obligated to satisfy any award of damages.

Last but not least, it is worth to mention that the Pfizer's CEO sold stock worth $5.6 million on same day as COVID-19 vaccine announcement.